New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 22, 2014
10:42 EDTSRPT, YOKU, NFLX Options with decreasing implied volatility: SRPT NFLX YOKU UVXY
News For SRPT;NFLX;YOKU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
January 20, 2015
14:04 EDTNFLXNetflix January weekly 345 straddle priced for 11% movement into Q4
Subscribe for More Information
08:11 EDTNFLXNetflix volatility increases into Q4 and outlook
Subscribe for More Information
January 16, 2015
11:16 EDTNFLXCBS, Viacom climb following Stifel upgrades
Shares of CBS (CBS) and Viacom (VIA, VIAB) are climbing after research firm Stifel upgraded the stocks to Buy from Hold. CBS owns the CBS network and other entertainment properties. Viacom owns a number of cable networks, including MTV and Nickelodeon. WHAT'S NEW: CBS' NFL rights leave it well-positioned to charge cable companies and other TV providers high fees, Stifel analyst Benjamin Mogil wrote in a note to investors today. Meanwhile, the company's strong ratings and lower production costs reduce its risk, Mogil stated. CBS has more opportunities when it comes to selling its content to Internet TV networks such as Netflix (NFLX), Mogil believes. The analyst set a $65 price target on the shares. Meanwhile, Mogil believes that Viacom should benefit from the adoption of ratings measurements other than Nielsen's (NLSN) tools. Viacom has complained that Nielsen's tools have underestimated its ratings by failing to adequately take into account new types of content consumption, the analyst noted. Viacom's recent expansion into new international markets should also improve its performance, Mogil stated. He set an $89 price target on the shares. ANOTHER TO WATCH: Mogil initiated coverage of Twenty-First Century Fox (FOXA) with a $41 price target and Buy rating, saying that the company is well-positioned to benefit from its wide range of sports programming. He set a $41 price target on the shares. PRICE ACTION: In late morning trading, CBS advanced 2.75% to $55, Viacom gained 2.5% to $68, and Twenty-First Century Fox rose 0.4% to $34.72.
11:02 EDTYOKUBofA/Merrill APAC equity derivatives analyst analyst/industry conference call
Subscribe for More Information
10:34 EDTNFLXNetflix January weekly volatility increases into Q4 and outlook
Netflix January weekly call option implied volatility is at 97, February is at 55, March is at 46; compared to its 26-week average of 37 according to Track Data, suggesting large near term price movement into the expected release of Q4 results on January 20.
10:01 EDTNFLXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:30 EDTNFLXNetflix results likely to beat expectations, says Cantor
Cantor expects Netflix's Q4 results to beat expectations. The firm views the company's 2015 original content as compelling and keeps a Buy rating on the shares.
08:57 EDTNFLXNetflix upgraded to Outperform at Cowen
Subscribe for More Information
06:09 EDTNFLXNetflix upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
January 15, 2015
15:26 EDTSRPTSarepta says no safety info or comparison in BioMarin presentation
Sarepta (SRPT) said that, given the small sample size of study 201/202, the company understood the importance of providing an "extensive amount of date" in order to understand eteplirsen's treatment effect. Sarepta has reported mITT data since week 24 and has continued to provide updates on this same mITT at every timepoint, the company said. BioMarin's (BMRN) presentation on Monday focused on extension phase and excluded dose-escalation phase and results during off-treatment periods, according to Sarepta. "Sarepta has regularly reported complete 201/202 safety data on all patients. No safety information or comparison [was included] in BioMarin's Monday presentation," Sarepta wrote in slides for its presentation at the JPMorgan Healthcare Conference.
07:59 EDTNFLXNetflix Q4 results should be in-line with expectations, says Canaccord
Canaccord said Q4 result for Netflix should be in-line with expectations, but its guidance on subscriptions will be the focus for investors. Canaccord believes the long term growth story for Netflix remains intact, even though near-term subscriber trends remain difficult to predict. Canaccord reiterates its Buy rating and $450 price target on Netflix shares.
07:13 EDTSRPTJPMorgan to hold a conference
Subscribe for More Information
January 14, 2015
14:29 EDTNFLXNetflix January weekly volatility elevated into Q4 and outlook
Netflix January weekly call option implied volatility is at 89, February is at 57, March is at 46; compared to its 26-week average of 37 according to Track Data, suggesting large near term price movement into the expected release of Q4 results on January 20.
14:15 EDTNFLXNetflix seen boosted by strong new content
Subscribe for More Information
10:00 EDTNFLXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:36 EDTNFLXActive equity options trading
Subscribe for More Information
08:30 EDTSRPTSarepta says first patient dosed in European Phase 1/II SRP-4053 study
Subscribe for More Information
07:57 EDTNFLXJPMorgan positive on Netflix into Q4 earnings
JPMorgan reiterates an Overweight rating on shares of Netflix with a $450 price target ahead of the company's Q4 results on January 20. The firm expects a "solid' report driven by the continued shift away from linear TV and positive seasonality. It also expects new content and traction in Western Europe to drive subscriber growth in 2015.
07:23 EDTNFLXNetflix upgraded to Buy from Hold at Stifel
Stifel upgrade Netflix to Buy with a $380 price target citing compelling risk/reward given strong content cycles that include a strong slate of originals, lowered expectations, and continued international expansion.
January 13, 2015
11:57 EDTNFLXNetflix, Kudelski Group enter product relationship, resolve patent litigation
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use